chronic hepatitis B

hepatitis B virus
Biotech

Vir's hep B program fails to hit efficacy mark in phase 2

Vir's sidelined hepatitis B candidate, designed to serve as a “functional cure,” has failed to achieve the efficacy results.
Gabrielle Masson May 9, 2025 9:35am
layoffs cuts workforce reduction chairs boxes fired

Arbutus jettisons 57% of staff, ends in-house research

Mar 27, 2025 11:11am
hepatitis B virus

GSK drops 1 potential 'cure' for hep B, focuses on bepirovirsen

Feb 5, 2025 6:00am
A double helix of DNA made up of musical notes The notes are in black against a grey-white background

Tune Tx's $175M series B to fund epigenetic HBV therapy's trials

Jan 13, 2025 8:23am
hepatitis B virus

GSK axes hepatitis B vaccine trial after missing efficacy goal

Dec 4, 2024 5:15am
A double helix of DNA made up of musical notes The notes are in black against a grey-white background

Tune’s HBV therapy hits the right notes in cells and mice

Dec 7, 2023 2:05pm